Skip to main content
. Author manuscript; available in PMC: 2018 Mar 21.
Published in final edited form as: Cancer. 2013 Jun 21;119(18):3393–3401. doi: 10.1002/cncr.28214

TABLE 3.

General Health, Functional Status, and Lost Productivity in Individuals With and Without a History of Cancer

Cancer

Breast (n = 825) Prostate (n = 598) Colorectal (n = 293) Short Survival Cancersa (n = 193) Multiple Cancers (n = 339) Other Single Cancers (n = 2699) No Cancer (n = 64,387) Pb
General health status
 Excellent/Very good 51.2 (46.8–55.5) 49.7 (44.6–54.9) 49.8 (42.9–56.6) 38.7 (30.4–47.8) 38.6 (31.3–46.5) 49.6 (47.3–51.9) 60.0 (59.2–60.8) <.0001
 Good 31.4 (27.9–35.0) 31.8 (27.1–37.0) 28.7 (22.5–35.8) 26.0 (19.0–34.4) 26.9 (21.2–33.4) 31.3 (29.1–33.6) 26.2 (25.7–26.8)
 Fair/Poor 17.5 (14.8–20.5) 18.4 (15.6–21.6) 21.5 (16.4–27.8) 35.3 (27.0–44.5) 34.5 (28.3–41.3) 19.1 (17.4–20.9) 13.7 (13.2–14.2)
Functional status
 Limitation in physical functioning 12.4 (10.3–14.8) 11.9 (9.4–14.9) 13.0 (9.8–17.0) 20.5 (15.8–26.0) 20.5 (16.2–25.5) 16.3 (14.8–17.8) 12.4 (11.8–13.0) <.0001
 Limitation in physical functioning >3 mo 10.6 (8.8–12.8) 10.5 (8.1–13.5) 12.4 (9.3–16.2) 17.7 (13.7–22.6) 18.9 (14.7–23.9) 14.6 (13.3–16.0) 11.1 (10.6–11.7) <.0001
Lost productivity
 Employed in past 12 months (age <65 y) 81.6 (77.0–85.4) 73.6 (62.8–82.2) 79.2 (67.0–87.8) 66.8 (52.0–78.9) 57.1 (45.2–68.2) 75.2 (72.3–77.9) 81.4 (80.7–82.0) <.0001
 Any limitation in work, housework, or school 8.8 (7.1–11.0) 9.4 (6.8–12.9) 10.4 (7.6–14.1) 17.5 (12.8–23.4) 15.1 (11.5–19.7) 12.5 (11.2–14.0) 8.5 (8.0–9.0) <.0001
 Completely unable to do activities 4.7 (3.5–6.2) 6.3 (4.4–9.1) 7.4 (5.2–10.6) 11.7 (8.3–16.4) 10.3 (7.7–13.8) 7.4 (6.3–8.6) 5.2 (4.8–5.6) <.0001
 Cognitive limitation 3.4 (2.4–4.8) 4.9 (3.5–6.9) 4.6 (2.9–7.4) 6.8 (4.5–10.1) 8.5 (6.1–11.6) 6.1 (5.1–7.2) 4.4 (4.1–4.7) <.0001

Data are presented as % (95% confidence interval). Predicted margins were determined using logistic regression models with age, comorbidities, race/ethnicity, and sex as covariates. Some sample sizes were smaller based on missing data on specific outcomes.

a

Cancers with <25% 5-year survival rate (liver, lung, pancreas, and stomach).

b

Wald test.

HHS Vulnerability Disclosure